m+Medelevator.RU
← Поиск публикаций
Chemistry & biodiversity · 2026

Synthesis, Characterization, and Inhibitory Potential of Fagonia arabica L. Phytochemicals Coated Gold Nanoparticles Against Drug-Resistant Mycobacterium tuberculosis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mukhtar Farwa, Khan Muhammad Tahir, Lodhi Madeeha Shahzad, Ahmad Irfan, Alshaya Dalal Sulaiman, Al-Qahtani Ahmed A, Khan Anwar Sheed, Clark Taane G

Аннотация

In the current study, a novel formulation comprising gold Nanoparticles (AuNPs) and Fagonia arabica L. (F. arabica L.) phytochemicals, was designed and conjugated to evaluate inhibitory potential against Mycobacterium tuberculosis (Mtb). The chemically synthesized AuNPs were characterized followed by anti-Mtb potential of F. arabica L. extracts were which is significantly increased when used as a conjugate with AuNPs. The drug-resistant Mtb isolates in MGIT show that F. arabica L. phytochemicals, in conjugation with AuNPs, exhibit greater inhibitory activity than plant extracts alone at a concentration of 4.28 µg/mL. In vivo analysis showed no significant toxicity of the nanoconjugates. The plant extract was analyzed using ultra-high performance liquid chromatography in which 17 antimycobacterial components, including 14 from Traditional Chinese Medicine Class, were also identified. While plant-mediated AuNPs synthesis and their general antibacterial properties have been reported, our study offers distinct novelty through the specific use of F. arabica L., direct comparison of chemical versus green synthesis, the efficacy against MDR clinical isolates, and combined in vitro efficacy and in vivo safety validation. Overall, a good anti-TB activity of F. arabica L. in conjugation with AuNPs was found, paving the way for the development of new anti-TB agents against drug-resistant Mtb.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты